Are OKT3 binding sites on T cells modulated or merely converted (blindfolded) by OKT3 during therapy?

Transplant Proc. 1989 Feb;21(1 Pt 1):987-8.
No abstract available

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antibodies, Monoclonal / analysis
  • Antibodies, Monoclonal / therapeutic use*
  • Antigens, Differentiation, T-Lymphocyte / analysis
  • Antigens, Differentiation, T-Lymphocyte / immunology*
  • Antigens, Surface / immunology
  • CD2 Antigens
  • CD3 Complex
  • Graft Rejection*
  • Humans
  • Kidney Transplantation*
  • Lymphocytes / immunology
  • Radioimmunoassay
  • Receptors, Antigen, T-Cell / analysis
  • Receptors, Antigen, T-Cell / immunology*
  • Receptors, Immunologic / analysis
  • Receptors, Immunologic / immunology*

Substances

  • Antibodies, Monoclonal
  • Antigens, Differentiation, T-Lymphocyte
  • Antigens, Surface
  • CD2 Antigens
  • CD3 Complex
  • Receptors, Antigen, T-Cell
  • Receptors, Immunologic